Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Seed CoTSE:7743 -0.37%70 EBITDA Margin % is 13.27% as of Mar. 2026, which is 12% below its 10-year median of 15.00. GuruFocus rates TSE:7743 with a GF Score™ of 70/100 and a GF Value™ of 円543.95 (Fairly Valued). The stock has 6 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Seed Co ranks better than 66.13% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Seed Co's EBITDA for the
six
months ended in Mar. 2026 was 円2,229 Mil. Seed Co's Revenue for the
six
months ended in Mar. 2026 was 円16,798 Mil. Therefore, Seed Co's EBITDA margin for the quarter that ended in Mar. 2026 was 13.27%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Seed Co EBITDA Margin % Related Terms
Seed Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Seed Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7743 vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Seed Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Seed Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Seed Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Seed Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Seed Co (TSE:7743) has a EBITDA Margin % of 13.27% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Seed Co and its competitors. This is 12% below median its historical median of 15.00. Over the past decade, Seed Co's EBITDA Margin % has ranged from 9.24 to 15.88. According to the industry distribution chart, Seed Co ranks #276 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 33.9%.
Is Seed Co's EBITDA Margin % too high?
Seed Co's current EBITDA Margin % of 13.27% is 12% below median its 10-year median of 15.00. Over the past 10 years, this metric has ranged from a low of 9.24 to a high of 15.88. The Medical Devices & Instruments industry median EBITDA Margin % is 7.52. Seed Co's value of 13.27% is 76.5% above this industry median. Based on the distribution chart, Seed Co ranks #276 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Seed Co has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Seed Co's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Seed Co ranks #276 out of 815 companies for EBITDA Margin %. This puts Seed Co in the upper half of its industry. The industry median EBITDA Margin % is 7.52. Seed Co's value of 13.27% is 76.5% above this benchmark. Historically, Seed Co's own EBITDA Margin % has ranged from 9.24 to 15.88 over the past decade. While the company's 10-year median is 15.00 vs. the industry median of 7.52, Seed Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.52, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Seed Co's current EBITDA Margin % of 13.27% is 76.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Seed Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Seed Co's current EBITDA Margin % is 13.27%, which is 12% below median its own 10-year median of 15.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seed Co stock overvalued right now?
Based on GuruFocus' analysis, Seed Co (TSE:7743) is currently considered Fairly Valued. The stock's GF Value™ is 円543.95, compared to a current price of 円535.00 — trading 1.6% below its estimated fair value. The current EBITDA Margin % is 13.27%, which is 12% below median its 10-year median of 15.00 and 76.5% above the Medical Devices & Instruments industry median of 7.52. Seed Co's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Seed Co (TSE:7743), the current EBITDA Margin % is 13.27% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Seed Co (TSE:7743) Overvalued in 2026?
Based on GuruFocus' analysis, Seed Co stock appears to be undervalued.
The current stock price of 円535.00 is trading 1.6% below its estimated GF Value™ of 円543.95.
GuruFocus considers Seed Co to be Fairly Valued.
Key valuation signals for TSE:7743:
EBITDA Margin %: 13.27% (12% below median its 10-year median of 15.00)
GF Value™: 円543.95 vs. price of 円535.00 (1.6% below fair value)
Industry Position: 76.5% above the Medical Devices & Instruments median (#276 of 815)
No single metric tells the full story. See the TSE:7743 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Seed Co Ltd is engaged in the manufacturing and sells of contact lenses, glasses frames, and other eye care products in Japan. Its main products include SEED 1dayPure daily disposable lenses, SEED Fine disposable lenses, SEED S-1 high oxygen permeability hard contact lenses.
70GF Score
Get the complete analysis for TSE:7743
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7743 has been successfully added to your 
